EUVIMEDEUVIMED entdecken
Crossref

Palladium-Catalyzed Site-Selective Hydrogenation of Unactivated Alkenes Directed by 8-Aminoquinoline Amides

Takahiro Shirai, Shinnosuke Tani, Ryo Nakajima, Takuya Kumamoto

Chemical and Pharmaceutical Bulletin · 2024

DOI: 10.1248/cpb.c24-00433 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical and Pharmaceutical Bulletin, 2024. Verfasst von Takahiro Shirai und 3 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Biomedical and Health Sciences, Hiroshima University. Hauptthemen laut MEDLINE: Alkenes, Palladium, Amides, Aminoquinolines. Die Arbeit nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlkenesPalladiumAmidesAminoquinolinesCatalysisHydrogenationMolecular Structure

Stichwörter der Autor:innen

directing grouphydrogenationhydrosilanesite-selectiveunactivated alkene

Substanzen

AlkenesPalladiumAmides8-aminoquinolineAminoquinolines

Autor:innen und Institutionen

  • Graduate School of Biomedical and Health Sciences, Hiroshima University.
  • School of Pharmaceutical Sciences, Hiroshima University.

Zitieren

APA

Shirai, T., Tani, S., Nakajima, R., & Kumamoto, T. (2024). Palladium-Catalyzed Site-Selective Hydrogenation of Unactivated Alkenes Directed by 8-Aminoquinoline Amides. Chemical and Pharmaceutical Bulletin. https://doi.org/10.1248/cpb.c24-00433

Vancouver

Shirai T, Tani S, Nakajima R, Kumamoto T. Palladium-Catalyzed Site-Selective Hydrogenation of Unactivated Alkenes Directed by 8-Aminoquinoline Amides. Chemical and Pharmaceutical Bulletin. 2024. doi:10.1248/cpb.c24-00433

BibTeX
@article{Shirai2024,
  author = {Shirai, Takahiro and Tani, Shinnosuke and Nakajima, Ryo and Kumamoto, Takuya},
  title = {Palladium-Catalyzed Site-Selective Hydrogenation of Unactivated Alkenes Directed by 8-Aminoquinoline Amides},
  journal = {Chemical and Pharmaceutical Bulletin},
  year = {2024},
  doi = {10.1248/cpb.c24-00433}
}
Kostenlos starten →